Stock PAREXEL INTERNATIONAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

PAREXEL International Corporation Stock

Equities

US6994621075

Biotechnology & Medical Research

Chart PAREXEL International Corporation

Dynamic Chart

Latest news about PAREXEL International Corporation

PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion RE
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion RE
PAREXEL International : Contract research firm Parexel International explores sale - sources RE
More news

Press releases PAREXEL International Corporation

Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships BU
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry BU
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry BU
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International BU
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management BU
More press releases

News in other languages on PAREXEL International Corporation

PAREXEL : ERWEITERT SEINE CLINICAL TRIAL SUPPLY UND LOGISTIK-SERVICES MIT DER ERÖFFUNG SEINES NEUEN EUROPÄISCHEN DISTRIBUTIONS- UND DIENSTLEISTUNGSZENTRUMS
More news

Managers and Directors - PAREXEL International Corporation

Managers TitleAgeSince
Duncan MacDonald CEO
 Chief Executive Officer 56 -
Gregory Rush DFI
 Director of Finance/CFO 56 -
Amy McKee CTO
 Chief Tech/Sci/R&D Officer 52 18-12-31
Members of the board TitleAgeSince
Sherilyn McCoy CHM
 Chairman 65 -
Duncan MacDonald CEO
 Chief Executive Officer 56 -
May Kin Ho BRD
 Director/Board Member 71 15-08-25
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.10% 42.07B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 42.16B
MODERNA, INC. Stock Moderna, Inc.
+4.43% 39.77B
CELLTRION, INC. Stock Celltrion, Inc.
-11.36% 26.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.67% 24.68B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.84% 18.68B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.20% 12.11B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.30% 11.99B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.91% 11.06B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock